Abstract
28P - Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/annonc/mdx138.005
Publication Date: May 1, 2017 | |
Citations: 1 | License type: publisher-specific-oa |
28P - Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have